Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis

American Journal of Psychiatry

Volumn 162, Issue 10, 2005, Pages 1785-1804

  Perkins, Diana O ^a   Gu, Hongbin ^a   Boteva, Kalina ^a   Lieberman, Jeffrey A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; FIRST EPISODE SCHIZOPHRENIA; HUMAN; META ANALYSIS; NEGATIVE SYNDROME; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOSIS; QUANTITATIVE ANALYSIS; RELAPSE; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BRAIN; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FOLLOW-UP STUDIES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 26444464824     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.10.1785     Document Type: Review

References (89)

1. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J: The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 2001; 50:884-897
2. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ: EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996; 22:305-326
3. Linszen D, Lenior M, de Haan L, Dingemans P, Gersons B: Early intervention, untreated psychosis and the course of early schizophrenia. Br J Psychiatry Suppl 1998; 172:84-89
4. Malla AK, Norman RM, Manchanda R, McLean TS, Harricharan R, Cortese L, Townsend LA, Scholten DJ: Status of patients with first-episode psychosis after one year of phase-specific community-oriented treatment. Psychiatr Serv 2002; 53:458-463
5. Johannessen JO, McGlashan TH, Larsen TK, Homeland M, Joa I, Mardal S, Kvebaek R, Friis S, Melle I, Opjordsmoen S, Simonsen E, Ulrik H, Vaglum P: Early detection strategies for untreated first-episode psychosis. Schizophr Res 2001; 51:39-46
6. Lieberman JA, Sheitman B, Chakos M, Robinson D, Schooler N, Keith S: The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol 1998; 18:20S-24S
7. McGlashan TH: Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 1999; 46:899-907
8. Bottlender R, Strauss A, Moller HJ: Impact of duration of symptoms prior to first hospitalisation on acute outcome in 998 schizophrenic patients. Schizophr Res 2000; 44:145-150
9. Bottlender R, Sato T, Jager M, Wegener U, Wittmann J, Strauss A, Moller HJ: The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res 2003; 62:37-44
10. Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T: Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004; 61: 143-150
11. Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, an der Heiden W, Nienhuis FJ, Walsh D: Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med 2000; 30:1155-1167
12. Harrigan SM, McGorry PD, Krstev H: Does treatment delay in first-episode psychosis really matter? Psychol Med 2003; 33: 97-110
13. Addington J, van Mastrigt S, Addington D: Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004; 34:277-284
14. Perkins D, Lieberman J, Gu H, Tonen M, McEvoy J, Green A, Zipursky R, Strakowski S, Sharma T, Kahn R, Gur R, Tollefson G: Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004; 185:18-24
15. Ho B-C, Andreasen NC, Flaum M, Nopoulos P, Miller D: Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157:808-815; correction, 2001; 158:986
16. Malla AK, Norman RM, Manchanda R, Townsend L: Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002; 32:1109-1119
17. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56:241-247
18. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R: Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 1998; 24:75-85
19. Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE: Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 1996; 153:519-525
20. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N: Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157:60-66
21. Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J: Is the association between duration of untreated psychosis and outcome confounded? a two year follow-up study of first-admitted patients. Schizophr Res 2001; 49:231-241
22. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC: A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986; 148:120-127
23. Drake RJ, Haley CJ, Akhtar S, Lewis SW: Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 2000; 177:511-515
24. Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM: West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177:207-211
25. Robinson DG, Woerner MG, Alvir JMJ, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999; 156:544-549
26. Madsen AL, Karle A, Rubin P, Cortsen M, Andersen HS, Hemmingsen R: Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment. Acta Psychiatr Scand 1999; 100:367-374
27. Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE: Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry 2000; 157: 1824-1828
28. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO: Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000; 45:1-9
29. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E: Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000; 176:173-176
30. Malla AK, Norman RMG, Manchanda R, Ahmed MR, Scholten D, Harricharan R, Cortese L, Takhar J: One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002; 54:231-242
31. Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins T, Barnes T: Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry Suppl 2002; 43:S38-S44
32. Norman RM, Townsend L, Malla AK: Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry 2001; 179:340-345
33. Ho B-C, Alicata D, Ward J, Moser DJ, O'Leary DS, Arndt S, Andreasen NC: Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry 2003; 160:142-148
34. Rund BR, Melle I, Friis S, Larsen TK, Midbøe LJ, Opjordsmoen S, Simonsen E, Vaglum P, McGlashan T: Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry 2004; 161:466-472
35. Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD: Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr Res 2002; 54:223-230
36. Townsend LA, Norman RM, Malla AK, Rychlo AD, Ahmed RR: Changes in cognitive functioning following comprehensive treatment for first episode patients with schizophrenia spectrum disorders. Psychiatry Res 2002; 113:69-81
37. Malla AK, Mittal C, Lee M, Scholten DJ, Assis L, Norman RM: Computed tomography of the brain morphology of patients with first-episode schizophrenic psychosis. J Psychiatry Neurosci 2002; 27:350-358
38. Fannon D, Chitnis X, Doku V, Tennakoon L, Ó'Ceallaigh S, Soni W, Sumich A, Lowe J, Santamaria M, Sharma T: Features of structural brain abnormality detected in first-episode psychosis. Am J Psychiatry 2000; 157:1829-1834
39. Verdoux H, Bergey C, Assens F, Abalan F, Gonzales B, Pauillac P, Fournet O, Liraud F, Beaussier JP, Gaussares C, Etchegaray B, Bourgeois M, van Os J: Prediction of duration of psychosis before first admission. Eur Psychiatry 1998; 13:346-352
40. Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, Ji Z, Koch G, Hamer RM: Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 2003; 28:995-1003
41. Ring N, Tantam D, Montague L, Newby D, Black D, Morris J: Gender differences in the incidence of definite schizophrenia and atypical psychosis-focus on negative symptoms of schizophrenia. Acta Psychiatr Scand 1991; 84:489-496
42. Huber G: The heterogeneous course of schizophrenia. Schizophr Res 1997; 28:177-185
43. Larsen TK, McGlashan TH, Moe LC: First-episode schizophrenia, I: early course parameters. Schizophr Bull 1996; 22:241-256
44. Rabiner CJ, Wegner JT, Kane JM: Outcome study of first-episode psychosis, I: relapse rates after 1 year. Am J Psychiatry 1986; 143:1155-1158
45. Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC: Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001; 47:215-222
46. Haas GL, Sweeney JA: Premorbid and onset features of first-episode schizophrenia. Schizophr Bull 1992; 18:373-386
47. Ucok A, Polat A, Gene A, Cakiotar S, Turan N: Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res 2004; 38:163-168
48. Kalla O, Aaltonen J, Wahlstrom J, Lehtinen V, Garcia Cabeza I, Gonzalez de Chavez M: Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain. Acta Psychiatr Scand 2002; 106:265-275
49. Kua J, Wong KE, Kua EH, Tsoi WF: A 20-year follow-up study on schizophrenia in Singapore. Acta Psychiatr Scand 2003; 108: 118-125
50. de Haan L, Linszen DH, Lenior ME, de Win ED, Gorsira R: Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophr Bull 2003; 29: 341-348
51. Hafner H, Riecher-Rossler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fatkenheuer B, Loffler W, van der Heiden W: IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992; 6:209-223
52. McGorry PD, Singh BS, Copolov DL, Kaplan I, Dossetor CR, Van Riel RJ: Royal Park Multidiagnostic Instrument for Psychosis, part II: development, reliability, and validity. Schizophr Bull 1990; 16:517-536
53. Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766-771
54. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
55. Fahndrich E, Stieglitz RD: Das AMDP System: Manual zur Dokumentation psychiatrischer Befunde, 6th Ed. Gottingen, Germany, Hogrefe, 1997
56. Wing JK, Cooper JE, Sartorius N: The Measurement and Classification of Psychiatric Symptoms. London, Cambridge University Press, 1974
57. Andreasen NC: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1983
58. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
59. Nuechterlein GK, Subotnik KL, Ventura J, Mintz J, Fogelson DL, Bartzokis G, Aravagiri M: Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry 2001; 158:1835-1842
60. Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F, van Os J: Medication adherence in psychosis: predictors and impact on outcome: a 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand 2000; 102:203-210
61. Coldham EL, Addington J, Addington D: Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002; 106:286-290
62. Larsen TK, Johannessen JO, Opjordsmoen S: First-episode schizophrenia with long duration of untreated psychosis: pathways to care. Br J Psychiatry Suppl 1998; 172:45-52
63. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR: Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992; 149:1183-1188
64. Haas GL, Garratt LS, Sweeney JA: Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 1998; 32:151-159
65. Larsen JK, Johannessen JO, Guldberg CA, Opjordsmoen S, Vaglum P, McGlashan TH: Early intervention programs in first-episode psychosis and reduction of duration of untreated psychosis. Schizophr Res 2000; 36:344-345
66. Robinson DG, Woerner MG, Alvir JMJ, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999; 156:544-549
67. Harrison G, Croudace T, Mason P, Glazebrook C, Medley I: Predicting the long-term outcome of schizophrenia. Psychol Med 1996; 26:697-705
68. Moller P: Duration of untreated psychosis: are we ignoring the mode of initial development? an extensive naturalistic case study of phenomenal continuity in first-episode schizophrenia. Psychopathology 2001; 34:8-14
69. Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R: Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand 1999; 100:119-125
70. Weinberger DR, McClure RK: Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry 2002; 59: 553-558
71. Robinson DG, Woerner MG, Alvir JM, Bilder RM, Hinrichsen GA, Lieberman JA: Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 2002; 57:209-219
72. Ran MS, Xiang MZ, Li SX, Shan YH, Huang MS, Li SG, Liu ZR, Chen EY, Chan CL: Prevalence and course of schizophrenia in a Chinese rural area. Aust NZ J Psychiatry 2003; 37:452-457
73. Cahn W, Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS: Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 2002; 59:1002-1010
74. Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R: Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001; 49:487-499
75. Ho B-C, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M: Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003; 60:585-594
76. Lieberman JA, Fenton WS: Delayed detection of psychosis: causes, consequences, and effect on public health. Am J Psychiatry 2000; 157:1727-1730
77. Lincoln C, Harrigan S, McGorry PD: Understanding the topography of the early psychosis pathways: an opportunity to reduce delays in treatment. Br J Psychiatry Suppl 1998; 172:21-25
78. Skeate A, Jackson C, Birchwood M, Jones C: Duration of untreated psychosis and pathways to care in first-episode psychosis: investigation of help-seeking behaviour in primary care. Br J Psychiatry Suppl 2002; 43:S73-S77
79. Addington J, van Mastrigt S, Hutchinson J, Addington D: Pathways to care: help seeking behaviour in first episode psychosis. Acta Psychiatr Scand 2002; 106:358-364
80. Marquis S, Moore MM, Howieson DB, Sexton G, Payami H, Kaye JA, Camicioli R: Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 2002; 59:601-606
81. Lieberman JA: Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia. J Clin Psychiatry 1999; 60(suppl 12):9-12
82. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire PK: Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361:281-288
83. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM: Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004; 161:473-479
84. McGorry PD: Evaluating the importance of reducing the duration of untreated psychosis. Aust NZ J Psychiatry 2000; 34(suppl):S145-S149
85. Lieberman JA: Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective. Biol Psychiatry 1999; 46:729-739
86. Margolis RL, Chuang DM, Post RM: Programmed cell death: implications for neuropsychiatric disorders. Biol Psychiatry 1994; 35:946-956
87. Fuller R, Nopoulos P, Arndt S, O'Leary D, Ho B-C, Andreasen NC: Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry 2002; 159: 1183-1189
88. Ang YG, Tan HY: Academic deterioration prior to first episode schizophrenia in young Singaporean males. Psychiatry Res 2004; 121:303-307
89. Waddington JL, Youssef HA, Kinsella A: Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med 1995; 25:849-857